InvestorsHub Logo
Followers 21
Posts 1210
Boards Moderated 0
Alias Born 05/06/2014

Re: doogdilinger post# 28289

Wednesday, 07/19/2017 4:44:08 PM

Wednesday, July 19, 2017 4:44:08 PM

Post# of 38634

The committees will be asked to discuss the overall risk-benefit profile of the product, and whether the applicant has demonstrated abuse-deterrent properties for their product that would support labeling.

Seems to me that labeling will certainly be on the agenda.